ArticleTurk gogus kalp damar cerrahisi dergisi2024
[MSB-06] Retrospective Cohort Analysis of Ventricular Assist Device Driveline Infections: A Single-Center Experience.
Article in Turk gogus kalp damar cerrahisi dergisi, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to discuss our approach to driveline infections (DLIs), which can be managed by debridement, open packing, delayed closure, closed catheter irrigation, and rectus muscle relocation, and define the risk factors. Methods: This retrospective study reviewed all patients who underwent ventricular assist device (VAD) implantation at our institution between May 2011 and May 2023. Demographic data, comorbidities, VAD type, time from VAD implantation to infection, microbiological testing, surgical debridement, antibiotic therapy, infectious symptoms, hospital readmissions, postoperative complications, and overall survival were evaluated. Results: During the study period, 90 patients underwent VAD implantation, and DLIs were detected in 20 patients. The mean VAD time was 561 days in all patients, and the mean VAD time was 1277 days in those with DLIs. A statistically significant relationship was found between the risk of DLI and the total duration of VAD time (p<0.05). Median time from VAD implantation to first DLI admission was 513 days. Most commonly detected pathogens were Staphylococcus spp. (64%) and Conclusion: Driveline infections endanger the final objectives of VAD therapy by disrupting patient autonomy, the chance of bridging to heart transplantation, and decreasing overall survival and quality of life. Management of DLI usually requires extended, repeated hospitalizations and intense outpatient care. Vacuum therapy and muscle relocation have emerged as essential adjuncts to treating DLIs. Surgical treatment modalities should be standardized.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.